Precision Targeting Of Every Patient’s Medical “Moment Of Truth”

Read this interview with Dr. Chris Mansi, CEO of Viz.ai, on how the company's AI software is becoming a standardsetter for broader patient engagement with big pharma from advancing clinical trials to launching the next generation of specialty medicines.